‌

US Patent 10071970 Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

Patent 10071970 was granted and assigned to Parion Sciences on September, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Parion Sciences

Current Assignee

Parion Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100719700

Patent Inventor Names

Michael R. Johnson0

Date of Patent

September 11, 2018

Patent Application Number

154523870

Date Filed

March 7, 2017

Patent Citations Received

‌

US Patent 10752597 3,5-diamino-6-chloro-N—(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide

‌

US Patent 11578042 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide

‌

US Patent 10246425 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds

Patent Primary Examiner

‌

Brian E McDowell

Patent abstract

This invention provides compounds of the formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10071970 Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API